Diagnosis of atrophic gastritis and prevention of its complications
- Authors: Didigova R.T.1, Malsagova I.Y.1, Buzurtanova M.B.1, Ugurchieva P.O.1, Magomaeva K.V.2, Teboeva M.B.1
-
Affiliations:
- Ingush State University
- A.O. Akhushkov Ingush Republican Clinical Hospital
- Issue: Vol 9, No 10 (2023)
- Pages: 108-113
- Section: REVIEWS
- URL: https://journals.eco-vector.com/2412-4036/article/view/626314
- DOI: https://doi.org/10.18565/therapy.2023.10.108–113
- ID: 626314
Cite item
Open Access
Access granted
Abstract
The purpose of current work is systematization of information concerning manifestations and early diagnosis of atrophic gastritis. In most countries, including Russia, mortality rates from stomach cancer are close to the incidence rates of stomach cancer, but are highly dependent on early diagnosis and successful treatment of the disease. All this makes the problem of atrophic gastritis to be acute and actual as a clinical and morphological marker of an increased risk of stomach cancer developing.
Full Text
About the authors
Rosa T. Didigova
Ingush State University
Author for correspondence.
Email: roza2007@mail.ru
MD, professor, head of the Department of hospital therapy, Ingush State University
Russian Federation, MagasInna Y. Malsagova
Ingush State University
Email: roza2007@mail.ru
PhD in Medical Sciences, associate professor of the Department of hospital therapy, Ingush State University
Russian Federation, MagasMilana B. Buzurtanova
Ingush State University
Email: roza2007@mail.ru
senior lecturer at the Department of hospital therapy, Ingush State University
Russian Federation, MagasPyatimat O. Ugurchieva
Ingush State University
Email: roza2007@mail.ru
senior lecturer at the Department of hospital therapy, Ingush State University
Russian Federation, MagasKhava V. Magomaeva
A.O. Akhushkov Ingush Republican Clinical Hospital
Email: roza2007@mail.ru
therapist at A.O. Akhushkov Ingush Republican Clinical Hospital
Russian Federation, NazranMalika B. Teboeva
Ingush State University
Email: roza2007@mail.ru
6th year student of the Faculty of general medicine, Ingush State University
Russian Federation, MagasReferences
- Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24): 6735–40.
- Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ. 2004; 157: 301–10.
- Graham D.Y., Rugge M., Genta R.M. Diagnosis: Gastric intestinal metaplasia – what to do next? Curr Opin Gastroenterol. 2019; 35(6): 535–43. https://dx.doi.org/10.1097/MOG.0000000000000576.
- Kato I., Tominaga S., Ito Y. et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res. 1992; 83(11): 1137–42. https://dx.doi.org/10.1111/j.1349-7006.1992.tb02736.x.
- Mera R.M., Bravo L.E., Camargo M.C. et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018; 67(7): 1239–46. https://dx.doi.org/10.1136/gutjnl-2016-311685.
- Ливзан М.А., Гаус О.В., Мозговой С.И. Хронический атрофический гастрит: тактика курации пациента. РМЖ. Медицинское обозрение. 2021; 5(6): 427–432. [Livzan M.A., Gaus O.V., Mozgovoi S.I. Chronic atrophic gastritis: Patient management. Russkiy meditsinskiy zhurnal. Meditsinskoye obozreniye = Russian Medical Journal. Medical Review. 2021; 5(6): 427–432 (In Russ.)]. https://dx.doi.org/10.32364/2587-6821-2021-5-6-427-432. EDN: UAXHUG.
- Ивашкин В.Т., Маев И.В., Лапина Т.Л. с соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 28(1): 55–70. Ivashkin V.T., Mayev I.V., Lapina T.L. et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian Gastroenterological Association. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28(1): 55–70 (In Russ.)]. https://dx.doi.org/10.22416/1382-4376-2018-28-1-55-70. EDN: YRHTSM.
- Бордин Д.С., Ливзан М.А. Консенсус Маастрихт VI опубликован: что нового? Эффективная фармакотерапия. 2022; 18(22): 72–85. [Bordin D.S., Livzan M.A. The consensus Maastricht VI is published: What’s new? Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2022; 18(22): 72–85 (In Russ.)]. https://dx.doi.org/10.33978/2307-3586-2022-18-22-72-84. EDN: ZEVYNS.
- Kamada T., Sato M., Tokutomi T. et al. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: A multicenter study. Biomed Res Int. 2015; 2015: 865146. https://dx.doi.org/10.1155/2015/865146.
- Seo G.H., Lee H. Chemopreventive effect of rebamipide against gastric cancer in patients who undergo endoscopic resection for early gastric neoplasms: A nationwide claims study. Digestion. 2019; 100(4): 221–28. https://dx.doi.org/10.1159/000495288.
- Pimentel-Nunes P., Libanio D., Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019; 51(4): 365–88. https://dx.doi.org/10.1055/a-0859-1883.
- Lenti M.V., Rugge M., Lahner E. et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020; 6(1): 56. https://dx.doi.org/10.1038/s41572-020-0187-8.
- Драпкина О.М., Дроздова Л.Ю., Авдеев С.Н. с соавт. Оказание амбулаторно-поликлинической медицинской помощи пациентам с хроническими заболеваниями, подлежащим диспансерному наблюдению, в условиях пандемии COVID-19. Временные методические рекомендации. Версия 2. Кардиоваскулярная терапия и профилактика. 2021; 20(8): 245–290. [Drapkina O.M., Drozdova L.Yu., Avdeev S.N. et al. The outpatient medical care in patients with chronic diseases under dispensary supervision in the conditions of the COVID-19 pandemic. Temporary guidelines. Version 2. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2021; 20(8): 245–290 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2021-3172. EDN: SRCERD.
Supplementary files
